PCN116 A SURVIVAL BASED COST-EFFECTIVENESS ANALYSIS OF 5 YEARS LETROZOLE VERSUS TAMOXIFEN AS ADJUVANT THERAPY IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER- CANADIAN PERSPECTIVE
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74367-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)74367-9/fulltext
Title :
PCN116 A SURVIVAL BASED COST-EFFECTIVENESS ANALYSIS OF 5 YEARS LETROZOLE VERSUS TAMOXIFEN AS ADJUVANT THERAPY IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER- CANADIAN PERSPECTIVE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74367-9&doi=10.1016/S1098-3015(10)74367-9
First page :
Section Title :
Open access? :
No
Section Order :
296